当前位置:首页 - 行情中心 - 蔚蓝生物(603739) - 财务分析

蔚蓝生物

(603739)

  

流通市值:29.00亿  总市值:29.00亿
流通股本:2.53亿   总股本:2.53亿

蔚蓝生物(603739)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.17亿元,每股收益0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益184083.27万元,未分配利润71613.13万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产302615.88万元,负债118532.61万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入286,784,227.661,198,902,103.15879,639,817.46543,942,046.84
营业总成本273,764,144.881,093,894,635.23820,194,683.19515,361,328.74
营业利润22,637,992.14122,900,605.7180,914,819.9444,527,215.36
利润总额22,654,914.38122,495,154.3780,861,221.6544,467,557.49
净利润17,162,518.08102,857,240.4367,167,455.236,879,427.3
其他综合收益-4,237.35573,111.07114,953.92238,324.42
综合收益总额17,158,280.73103,430,351.567,282,409.1237,117,751.72
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,109,221,367.631,123,941,191.151,136,872,000.391,100,929,315.12
非流动资产合计1,916,937,447.991,910,116,434.181,789,201,403.331,696,856,200.99
资产总计3,026,158,815.623,034,057,625.332,926,073,403.722,797,785,516.11
流动负债合计1,068,439,041.971,088,173,698.02887,871,532.61825,973,653.91
非流动负债合计116,887,083.94120,498,021.23226,577,122.7225,777,132.92
负债合计1,185,326,125.91,208,671,719.251,114,448,655.311,051,750,786.83
归属于母公司股东权益合计1,722,773,343.781,708,293,232.641,691,711,098.331,656,926,396.06
股东权益合计1,840,832,689.721,825,385,906.081,811,624,748.411,746,034,729.28
负债和股东权益合计3,026,158,815.623,034,057,625.332,926,073,403.722,797,785,516.11
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计317,112,598.931,307,242,389.37981,224,016.17630,753,516.64
经营活动现金流出小计330,620,076.261,153,650,067.66936,002,443.96610,145,402.77
经营活动产生的现金流量净额-13,507,477.33153,592,321.7145,221,572.2120,608,113.87
投资活动现金流入小计17,749,411.51707,006,401.96596,532,422.03495,460,405.75
投资活动现金流出小计82,734,088.081,003,662,454.14804,224,932.87623,858,787.52
投资活动产生的现金流量净额-64,984,676.57-296,656,052.18-207,692,510.84-128,398,381.77
筹资活动现金流入小计129,960,000674,676,448.98511,519,738.3351,387,613.39
筹资活动现金流出小计90,679,971.41518,316,133.87328,379,822.44171,668,765.31
筹资活动产生的现金流量净额39,280,028.59156,360,315.11183,139,915.86179,718,848.08
汇率变动对现金及现金等价物的影响-732,125.65--
现金及现金等价物净增加额-39,212,125.3114,028,710.2920,668,977.2371,928,580.18
期末现金及现金等价物余额182,508,822.05221,720,947.36228,361,214.3279,620,817.25
TOP↑